Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Mar;1(1):61-4.

Aqueous humor and serum penetration of tacrolimus after topical and oral administration in rats: an absorption study

Affiliations
Free PMC article

Aqueous humor and serum penetration of tacrolimus after topical and oral administration in rats: an absorption study

F Nilüfer Yalçindağ et al. Clin Ophthalmol. 2007 Mar.
Free PMC article

Abstract

Purpose: To investigate the penetration of tacrolimus to the aqueous and serum after topical and oral administration.

Methods: Thirty Wistar rats were divided into three groups. In the first group (n = 12), a single dose of 0.3 % isotonic tacrolimus solution was applied topically to the rat eyes. The second group (n = 12), received 0.1 mg/kg/day tacrolimus for three days. In control group (n = 6), the rats were administered a single drop of 0.3% salin solution topically. Following collection of samples, the amounts of tacrolimus in aqueous and serum samples were compared with each other.

Results: In group I, the mean concentration of tacrolimus was 35.16 ng/ml in aqueous and 2.22 ng/ml in serum. In group II, the mean concentration of tacrolimus was 13.08 ng/ml in aqueous and 13.45 ng/ml in serum. There was no significant difference in the serum concentration levels of tacrolimus between group I and control group. However there was a significant difference of the drug concentrations in aqueous between the groups (p < 0.001). The mean aqueous and serum concentrations of tacrolimus in group II, differed significantly from the mean concentrations in group I (p < 0.001) and the control group (p < 0.001).

Conclusion: Tacrolimus may be a promising treatment modality in intraocular inflammation by topical application besides systemic administration.

Keywords: FK506; humor aqueous; penetration into the eye; systemic application; tacrolimus; topical application.

PubMed Disclaimer

References

    1. Dua HS, Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol. 1999;83:414–19. - PMC - PubMed
    1. Fitzgerald P, Hadgraft J, Wilson CG. A gamma-scintigraphic evaluation of microparticulate ophthalmic delivery systems: liposomes and nanoparticles. Int J Pharm. 1987;40:81–8.
    1. Hikita N, Chan CC, Whitcup SM, et al. Effects of topical FK506 on endotoxin-induced uveitis (EIU) in the Lewis rat. Curr Eye Res. 1995;14:209–14. - PubMed
    1. Hikita N, Lopez JS, Chan CC, et al. Use of topical FK506 in a corneal graft rejection model in Lewis rats. Invest Ophthalmol Vis Sci. 1997;38:901–9. - PubMed
    1. Honbo T, Koyabashi M, Hane K, et al. The oral dosage form of FK-506. Transplant Proc. 1987;19(Suppl. 6):17–22. - PubMed

LinkOut - more resources